These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 25849097)

  • 21.
    Agarwal P; Anvikar AR; Pillai CR; Srivastava K
    Indian J Med Res; 2017 Nov; 146(5):622-628. PubMed ID: 29512604
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro sensitivities of Plasmodium falciparum to different antimalarial drugs in Uganda.
    Nsobya SL; Kiggundu M; Nanyunja S; Joloba M; Greenhouse B; Rosenthal PJ
    Antimicrob Agents Chemother; 2010 Mar; 54(3):1200-6. PubMed ID: 20065051
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association between Polymorphisms in the Pf
    Gendrot M; Diawara S; Madamet M; Kounta MB; Briolant S; Wade KA; Fall M; Benoit N; Nakoulima A; Amalvict R; Diémé Y; Fall B; Wade B; Diatta B; Pradines B
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28052850
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro activity of iron-binding compounds against Senegalese isolates of Plasmodium falciparum.
    Pradines B; Tall A; Ramiandrasoa F; Spiegel A; Sokhna C; Fusai T; Mosnier J; Daries W; Trape JF; Kunesch G; Parzy D; Rogier C
    J Antimicrob Chemother; 2006 Jun; 57(6):1093-9. PubMed ID: 16595639
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of in vitro resistance to eleven standard or new antimalarial drugs among Plasmodium falciparum isolates from Pointe-Noire, Republic of the Congo.
    Pradines B; Hovette P; Fusai T; Atanda HL; Baret E; Cheval P; Mosnier J; Callec A; Cren J; Amalvict R; Gardair JP; Rogier C
    J Clin Microbiol; 2006 Jul; 44(7):2404-8. PubMed ID: 16825356
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A SYBR Green 1-based in vitro test of susceptibility of Ghanaian Plasmodium falciparum clinical isolates to a panel of anti-malarial drugs.
    Quashie NB; Duah NO; Abuaku B; Quaye L; Ayanful-Torgby R; Akwoviah GA; Kweku M; Johnson JD; Lucchi NW; Udhayakumar V; Duplessis C; Kronmann KC; Koram KA
    Malar J; 2013 Dec; 12():450. PubMed ID: 24341604
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ex vivo piperaquine resistance developed rapidly in Plasmodium falciparum isolates in northern Cambodia compared to Thailand.
    Chaorattanakawee S; Lon C; Jongsakul K; Gawee J; Sok S; Sundrakes S; Kong N; Thamnurak C; Chann S; Chattrakarn S; Praditpol C; Buathong N; Uthaimongkol N; Smith P; Sirisopana N; Huy R; Prom S; Fukuda MM; Bethell D; Walsh DS; Lanteri C; Saunders D
    Malar J; 2016 Oct; 15(1):519. PubMed ID: 27769299
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [In vitro sensitivity of 85 Plasmodium falciparum isolates in the Fatick region, Senegal].
    Pradines B; Rogier C; Fusai T; Tall A; Trape JF; Doury JC
    Med Trop (Mars); 1996; 56(2):141-5. PubMed ID: 8926873
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro sensitivity of Plasmodium falciparum to conventional and novel antimalarial drugs in Papua New Guinea.
    Wong RP; Lautu D; Tavul L; Hackett SL; Siba P; Karunajeewa HA; Ilett KF; Mueller I; Davis TM
    Trop Med Int Health; 2010 Mar; 15(3):342-9. PubMed ID: 20070627
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro susceptibility of Plasmodium falciparum isolates from Abidjan, Côte d'Ivoire, to artemisinin, chloroquine, dihydroartemisinin and pyronaridine.
    Brice BK; William Y; Lacina O; Félix Y; Hugues A; Léonardo B; André M; Joseph D
    Tanzan J Health Res; 2010 Jan; 12(1):73-9. PubMed ID: 20737832
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro antimalarial drug susceptibility in Thai border areas from 1998-2003.
    Chaijaroenkul W; Bangchang KN; Mungthin M; Ward SA
    Malar J; 2005 Aug; 4():37. PubMed ID: 16060967
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Piperaquine resistant Cambodian Plasmodium falciparum clinical isolates: in vitro genotypic and phenotypic characterization.
    Boonyalai N; Vesely BA; Thamnurak C; Praditpol C; Fagnark W; Kirativanich K; Saingam P; Chaisatit C; Lertsethtakarn P; Gosi P; Kuntawunginn W; Vanachayangkul P; Spring MD; Fukuda MM; Lon C; Smith PL; Waters NC; Saunders DL; Wojnarski M
    Malar J; 2020 Jul; 19(1):269. PubMed ID: 32711538
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [In vitro susceptibility of Colombian Plasmodium falciparum isolates to different antimalarial drugs].
    Arango E; Carmona-Fonseca J; Blair S
    Biomedica; 2008 Jun; 28(2):213-23. PubMed ID: 18719723
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Artemisinin derivatives and malaria: useful, in combination with other antimalarials.
    Prescrire Int; 2008 Aug; 17(96):162-8. PubMed ID: 19492494
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Madagascan isolates of Plasmodium falciparum showing low sensitivity to artemether in vitro.
    Randrianarivelojosia M; Raharimalala LA; Randrianasolo L; Ratsimbasoa A; Rason MA; Ariey F; Jambou R
    Ann Trop Med Parasitol; 2001 Apr; 95(3):237-43. PubMed ID: 11339883
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro sensitivity of Plasmodium falciparum to amodiaquine compared with other major antimalarials in Madagascar.
    Randrianarivelojosia M; Harisoa JL; Rabarijaona LP; Raharimalala LA; Ranaivo L; Pietra V; Duchemin JB; Rakotomanana F; Robert V; Mauclere P; Ariey F
    Parassitologia; 2002 Dec; 44(3-4):141-7. PubMed ID: 12701375
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro monitoring of Plasmodium falciparum susceptibility to artesunate, mefloquine, quinine and chloroquine in Cambodia: 2001-2002.
    Lim P; Chim P; Sem R; Nemh S; Poravuth Y; Lim C; Seila S; Tsuyuoka R; Denis MB; Socheat D; Fandeur T
    Acta Trop; 2005 Jan; 93(1):31-40. PubMed ID: 15589795
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dihydroethanoanthracene derivatives reverse in vitro quinoline resistance in Plasmodium falciparum malaria.
    Henry M; Alibert S; Baragatti M; Mosnier J; Baret E; Amalvict R; Legrand E; Fusai T; Barbe J; Rogier C; Pagès JM; Pradines B
    Med Chem; 2008 Sep; 4(5):426-37. PubMed ID: 18782039
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PfMDR2 and PfMDR5 are dispensable for Plasmodium falciparum asexual parasite multiplication but change in vitro susceptibility to anti-malarial drugs.
    van der Velden M; Rijpma SR; Russel FG; Sauerwein RW; Koenderink JB
    Malar J; 2015 Feb; 14():76. PubMed ID: 25884516
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Investigating the Efficacy of Triple Artemisinin-Based Combination Therapies for Treating Plasmodium falciparum Malaria Patients Using Mathematical Modeling.
    Dini S; Zaloumis S; Cao P; Price RN; Fowkes FJI; van der Pluijm RW; McCaw JM; Simpson JA
    Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30150462
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.